Lori A Cross, NP | |
611 W. Park St., Urbana, IL 61801-2500 | |
(217) 904-7000 | |
(217) 904-7742 |
Full Name | Lori A Cross |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 10 Years |
Location | 611 W. Park St., Urbana, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386064897 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 041348311 (Illinois) | Secondary |
363L00000X | Nurse Practitioner | 209011979 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Carle Foundation Hospital | Urbana, IL | Hospital |
Carle Hoopeston Regional Health Center | Hoopeston, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Carle Health Care Incorporated | 3577515774 | 808 |
News Archive
The number of jail inmates in California taking psychotropic drugs has jumped about 25 percent in five years, and they now account for about a fifth of the county jail population across the state, according to a new analysis of state data.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A new study identifies six main patient-reported barriers to receiving quality end-of-life (EOL) care among ethnic minority populations. The biggest barrier is lack of sufficient financial resources and insurance, according to the article published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Experts of the Department of Medical Physiology of the University of Granada (EFFECTS-262 research group) are leading a national research to measure the level of physical fitness of Spanish teenagers and its connection with their future cardiovascular health. The study, called AVENA, reveals that the cardiorespiratory fitness level of one out of five teenagers indicates there is a risk of having cardiovascular diseases in the future.
› Verified 8 days ago
Entity Name | Carle Health Care Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
The number of jail inmates in California taking psychotropic drugs has jumped about 25 percent in five years, and they now account for about a fifth of the county jail population across the state, according to a new analysis of state data.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A new study identifies six main patient-reported barriers to receiving quality end-of-life (EOL) care among ethnic minority populations. The biggest barrier is lack of sufficient financial resources and insurance, according to the article published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Experts of the Department of Medical Physiology of the University of Granada (EFFECTS-262 research group) are leading a national research to measure the level of physical fitness of Spanish teenagers and its connection with their future cardiovascular health. The study, called AVENA, reveals that the cardiorespiratory fitness level of one out of five teenagers indicates there is a risk of having cardiovascular diseases in the future.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Lori A Cross, NP 611 W. Park St., Bwpc, Urbana, IL 61801-2500 Ph: (217) 383-6941 | Lori A Cross, NP 611 W. Park St., Urbana, IL 61801-2500 Ph: (217) 904-7000 |
News Archive
The number of jail inmates in California taking psychotropic drugs has jumped about 25 percent in five years, and they now account for about a fifth of the county jail population across the state, according to a new analysis of state data.
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
New research is shedding light on why estrogenic hormones produce unintended results in women, giving hope to the idea that new drugs might reach their targets and work more effectively. Ultimately it could mean that postmenopausal women would know that hormone-replacement therapy would have only its intended result.
A new study identifies six main patient-reported barriers to receiving quality end-of-life (EOL) care among ethnic minority populations. The biggest barrier is lack of sufficient financial resources and insurance, according to the article published in Journal of Palliative Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Experts of the Department of Medical Physiology of the University of Granada (EFFECTS-262 research group) are leading a national research to measure the level of physical fitness of Spanish teenagers and its connection with their future cardiovascular health. The study, called AVENA, reveals that the cardiorespiratory fitness level of one out of five teenagers indicates there is a risk of having cardiovascular diseases in the future.
› Verified 8 days ago
Lindy Drollinger, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 610 N. Lincoln Ave., Neurosurgery, Urbana, IL 61801 Phone: 217-383-3507 Fax: 217-383-3171 | |
Emily Remington, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3140 Fax: 217-383-4966 | |
Kendall E Wallace, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 | |
Jiaqiu Sinha, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 509 W University Ave, Urbana, IL 61801 Phone: 217-383-6645 | |
Mrs. Doris M Lawyer, CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1109 S Lincoln Ave, Urbana, IL 61801 Phone: 217-333-2711 | |
Peter Kale, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1818 E. Windsor Road, Adult Medicine/geriatrics, Urbana, IL 61802 Phone: 217-255-9672 Fax: 217-383-4681 | |
Kelly Johnson, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1818 E. Windsor Road, Urbana, IL 61802 Phone: 217-255-9670 Fax: 217-255-9724 |